FdaApplication

ANDA 211783

Back to search

Identifiers

Properties

PropertyValue
applicant_nameXIROMED PHARMA ESPANA SL
application_typeANDA
approval_date2022-08-10

Products (3)

ProductActive ingredientStrengthDosage form
ESTRADIOLESTRADIOL0.1% (1GM/PACKET)GEL;TRANSDERMAL
ESTRADIOLESTRADIOL0.1% (0.25GM/PACKET)GEL;TRANSDERMAL
ESTRADIOLESTRADIOL0.1% (0.5GM/PACKET)GEL;TRANSDERMAL

3 products